# Laboratory Validation for Hereditary Tyrosinemia 1 \(HT1\)

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS england](/buyers/nhs-england/contract-awards)
- Contract winner: Synnovis LLP
- Award value: £28,245
- Tender value: £28,245
- Award date: 25 March 2024
- Published: 23 April 2024
- Contract start: 1 February 2024
- Contract end: 31 July 2024
- Stage: awarded
- Procurement category: services
- Notice ID: 4dfc4461-c810-41e0-a7b0-52c2eaf9b34c-743361
- OCID: ocds-b5fd17-40c12368-8dfa-42e1-8774-c4362996f41f

## Description

Stage 1 of Hereditary Tyrosinaemia 1 implementation: Laboratory validation and verification of non-derivatised MSMS kits for use when screening for HT1 using succinylacetone measurement in dried blood spot samples in 3 laboratories\.

## Related contract awards

- [Octopus Deploy Licences](/contracts/ocds-b5fd17-7a50c677-d509-477a-8a8c-7cb6cd368b45): NHS England
- [Transforming &amp; Connecting Care Technology Delivery Service - Enablement Phase](/contracts/ocds-b5fd17-c4e27516-00fe-4409-9b4a-f1a27f7410a0): NHS England
- [NASSTAR T1510 WTE Teams Telephony](/contracts/ocds-b5fd17-1bdf9a7a-14ea-4c0c-be0c-39fd8574a761): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/4dfc4461-c810-41e0-a7b0-52c2eaf9b34c-743361)
